Literature DB >> 35089584

Coordinated regulation of interferon and inflammasome signaling pathways by SARS-CoV-2 proteins.

Na-Eun Kim1, Yoon-Jae Song2.   

Abstract

Type I and III interferons (IFNs) and the nucleotide-binding domain (NBD) leucine-rich repeat (LRR)-containing receptor (NLR) family pyrin domain containing 3 (NLRP3) inflammasome play pivotal roles in the pathogenesis of SARS-CoV-2. While optimal IFN and inflammasome responses are essential for limiting SARS-CoV-2 infection, aberrant activation of these innate immune responses is associated with COVID-19 pathogenesis. In this review, we focus our discussion on recent findings on SARS-CoV-2-induced type I and III IFNs and NLRP3 inflammasome responses and the viral proteins regulating these mechanisms.
© 2022. The Microbiological Society of Korea.

Entities:  

Keywords:  inflammasome; interferon; severe acute respiratory syndrome corona virus 2

Mesh:

Substances:

Year:  2022        PMID: 35089584      PMCID: PMC8795727          DOI: 10.1007/s12275-022-1502-8

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   2.902


  75 in total

1.  ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity.

Authors:  GuanQun Liu; Jung-Hyun Lee; Zachary M Parker; Dhiraj Acharya; Jessica J Chiang; Michiel van Gent; William Riedl; Meredith E Davis-Gardner; Effi Wies; Cindy Chiang; Michaela U Gack
Journal:  Nat Microbiol       Date:  2021-03-16       Impact factor: 17.745

2.  RIG-I-like receptors direct inflammatory macrophage polarization against West Nile virus infection.

Authors:  Amy E L Stone; Richard Green; Courtney Wilkins; Emily A Hemann; Michael Gale
Journal:  Nat Commun       Date:  2019-08-13       Impact factor: 14.919

3.  Antiviral activities of type I interferons to SARS-CoV-2 infection.

Authors:  Emily Mantlo; Natalya Bukreyeva; Junki Maruyama; Slobodan Paessler; Cheng Huang
Journal:  Antiviral Res       Date:  2020-04-29       Impact factor: 5.970

4.  SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.

Authors:  Sin-Yee Fung; Kam-Leung Siu; Huayue Lin; Man Lung Yeung; Dong-Yan Jin
Journal:  Int J Biol Sci       Date:  2021-04-10       Impact factor: 6.580

5.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.

Authors:  Yi Zheng; Meng-Wei Zhuang; Lulu Han; Jing Zhang; Mei-Ling Nan; Peng Zhan; Dongwei Kang; Xinyong Liu; Chengjiang Gao; Pei-Hui Wang
Journal:  Signal Transduct Target Ther       Date:  2020-12-28

6.  Functional landscape of SARS-CoV-2 cellular restriction.

Authors:  Laura Martin-Sancho; Mary K Lewinski; Lars Pache; Charlotte A Stoneham; Xin Yin; Mark E Becker; Dexter Pratt; Christopher Churas; Sara B Rosenthal; Sophie Liu; Stuart Weston; Paul D De Jesus; Alan M O'Neill; Anshu P Gounder; Courtney Nguyen; Yuan Pu; Heather M Curry; Aaron L Oom; Lisa Miorin; Ariel Rodriguez-Frandsen; Fan Zheng; Chunxiang Wu; Yong Xiong; Matthew Urbanowski; Megan L Shaw; Max W Chang; Christopher Benner; Thomas J Hope; Matthew B Frieman; Adolfo García-Sastre; Trey Ideker; Judd F Hultquist; John Guatelli; Sumit K Chanda
Journal:  Mol Cell       Date:  2021-04-13       Impact factor: 17.970

7.  Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.

Authors:  Raphaël Cauchois; Marie Koubi; David Delarbre; Cécile Manet; Julien Carvelli; Valery Benjamin Blasco; Rodolphe Jean; Louis Fouche; Charleric Bornet; Vanessa Pauly; Karin Mazodier; Vincent Pestre; Pierre-André Jarrot; Charles A Dinarello; Gilles Kaplanski
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-22       Impact factor: 11.205

8.  Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2.

Authors:  Qi Peng; Ruchao Peng; Bin Yuan; Jingru Zhao; Min Wang; Xixi Wang; Qian Wang; Yan Sun; Zheng Fan; Jianxun Qi; George F Gao; Yi Shi
Journal:  Cell Rep       Date:  2020-05-30       Impact factor: 9.423

9.  A Comparative Analysis of Coronavirus Nucleocapsid (N) Proteins Reveals the SADS-CoV N Protein Antagonizes IFN-β Production by Inducing Ubiquitination of RIG-I.

Authors:  Yan Liu; Qi-Zhang Liang; Wan Lu; Yong-Le Yang; Ruiai Chen; Yao-Wei Huang; Bin Wang
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

10.  Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

Authors:  Paul Bastard; Lindsey B Rosen; Qian Zhang; Eleftherios Michailidis; Hans-Heinrich Hoffmann; Yu Zhang; Karim Dorgham; Quentin Philippot; Jérémie Rosain; Vivien Béziat; Steven M Holland; Guy Gorochov; Emmanuelle Jouanguy; Charles M Rice; Aurélie Cobat; Luigi D Notarangelo; Laurent Abel; Helen C Su; Jean-Laurent Casanova; Jérémy Manry; Elana Shaw; Liis Haljasmägi; Pärt Peterson; Lazaro Lorenzo; Lucy Bizien; Sophie Trouillet-Assant; Kerry Dobbs; Adriana Almeida de Jesus; Alexandre Belot; Anne Kallaste; Emilie Catherinot; Yacine Tandjaoui-Lambiotte; Jeremie Le Pen; Gaspard Kerner; Benedetta Bigio; Yoann Seeleuthner; Rui Yang; Alexandre Bolze; András N Spaan; Ottavia M Delmonte; Michael S Abers; Alessandro Aiuti; Giorgio Casari; Vito Lampasona; Lorenzo Piemonti; Fabio Ciceri; Kaya Bilguvar; Richard P Lifton; Marc Vasse; David M Smadja; Mélanie Migaud; Jérome Hadjadj; Benjamin Terrier; Darragh Duffy; Lluis Quintana-Murci; Diederik van de Beek; Lucie Roussel; Donald C Vinh; Stuart G Tangye; Filomeen Haerynck; David Dalmau; Javier Martinez-Picado; Petter Brodin; Michel C Nussenzweig; Stéphanie Boisson-Dupuis; Carlos Rodríguez-Gallego; Guillaume Vogt; Trine H Mogensen; Andrew J Oler; Jingwen Gu; Peter D Burbelo; Jeffrey I Cohen; Andrea Biondi; Laura Rachele Bettini; Mariella D'Angio; Paolo Bonfanti; Patrick Rossignol; Julien Mayaux; Frédéric Rieux-Laucat; Eystein S Husebye; Francesca Fusco; Matilde Valeria Ursini; Luisa Imberti; Alessandra Sottini; Simone Paghera; Eugenia Quiros-Roldan; Camillo Rossi; Riccardo Castagnoli; Daniela Montagna; Amelia Licari; Gian Luigi Marseglia; Xavier Duval; Jade Ghosn; John S Tsang; Raphaela Goldbach-Mansky; Kai Kisand; Michail S Lionakis; Anne Puel; Shen-Ying Zhang
Journal:  Science       Date:  2020-09-24       Impact factor: 63.714

View more
  2 in total

Review 1.  The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2.

Authors:  Davide Ferrari; Michele Rubini; Jorge S Burns
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

2.  Two years of COVID-19 pandemic: where are we now?

Authors:  Jinjong Myoung
Journal:  J Microbiol       Date:  2022-03       Impact factor: 3.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.